PI Post Acute Access Act

PI Post Acute Access Act

This bill allows for separate payment under Medicare to skilled nursing facilities for items and services that are needed to administer intravenous immune globin (IVIG) to patients with primary immune deficiency diseases (rare genetic disorders that impair the immune system and increase vulnerability for other infections).

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3379 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 3379

 To amend title XVIII of the Social Security Act to improve access to 
   skilled nursing facilities for primary immunodeficiency patients.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 16, 2023

    Ms. Matsui (for herself and Mr. Johnson of Ohio) introduced the 
following bill; which was referred to the Committee on Ways and Means, 
 and in addition to the Committee on Energy and Commerce, for a period 
    to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
 To amend title XVIII of the Social Security Act to improve access to 
   skilled nursing facilities for primary immunodeficiency patients.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``PI Post Acute Access Act''.

SEC. 2. IMPROVING ACCESS TO SKILLED NURSING FACILITY SERVICES FOR 
              PRIMARY IMMUNODEFICIENCY PATIENTS.

    (a) In General.--Section 1888(e)(2)(A)(iii) of the Social Security 
Act (42 U.S.C. 1395yy(e)(2)(A)(iii)) is amended by adding at the end 
the following new subclause:
                                    ``(VII) Items and services needed 
                                for the administration of intravenous 
                                immune globin for the treatment of 
                                primary immune deficiency disease.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply to items and services furnished on or after January 1, 2024.
                                 <all>